FDA Approves First-Line Treatment for NSCLC with PD-L1 Biomarker Bethany Johnson (GO2 for Lung Cancer)2020-04-17T11:25:41-05:00April 12th, 2019|Hot Topics, News, Press Releases, Science and Research| Read More 3
